SCHEMBL6551997

SCHEMBL6551997

Cc1ccc(Cc2nc(C(=O)O)[nH]c2Cc2ccc(C)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.45
SRD5A2 P31213 1/20 0.45
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
LTB4R Q15722 1/20 0.41
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 2/20 0.39
DPP4 P27487 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
BRS3 P32247 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
P2RX3 P56373 1/20 0.36
RXFP1 Q9HBX9 2/20 0.36
TP53 P04637 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6552425 0.85 LTB4R (0.57) KDM4EGAALTB4RHSD17B10ALDH1A1
SCHEMBL7044623 0.85 NPC1 (0.43) SRD5A2GAARAB9ALTB4RALDH1A1
SCHEMBL7044697 0.84 RHEB (0.45) KDM4ERAB9ALTB4RALDH1A1BRS3
SCHEMBL7044996 0.84 TRPM8 (0.46) KDM4EGAARAB9AHSD17B10ALDH1A1
SCHEMBL7042640 0.81 SMN1; SMN2 (0.46) RAB9AALDH1A1TP53MEN1LMNA
SCHEMBL6553813 0.81 MMP2 (0.48) KDM4ERAB9ALTB4RALDH1A1MEN1
SCHEMBL7044700 0.80 SMN1; SMN2 (0.52) KDM4ERAB9AHSD17B10ALDH1A1RXFP1
SCHEMBL7044713 0.79 RXFP1 (0.41) KDM4EGAARAB9ARXFP1TP53
SCHEMBL15964617 0.76 SRD5A2 (0.49) PIN1SRD5A2KDM4EGAARAB9A
SCHEMBL7044203 0.76 SMN1; SMN2 (0.51) RAB9AALDH1A1TP53MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482794-A1 METHOD OF TREATMENT OR PREVENTION OF OBESITY Merck & Co., Inc. (US) 2004-12-08 EP disclosed
WO-2003075660-A1 METHOD OF TREATMENT OR PREVENTION OF OBESITY MERCK & CO., INC. (US) 2003-09-18 WO disclosed
WO-2003007887-A2 SUBSTITUTED IMIDAZOLES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-01-30 WO disclosed